Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OptimaCC: Epinephrine vs Norepinephrine in Cardiogenic Shock
NCT01367743Phase 4Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Sep 2011
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cardiogenic shock comparing Epinephrine with Norepinephrine (2 arms). Primary endpoint: Cardiac Index Evolution. Started Sep 2011; status: completed.
02
Drugs
epinephrinenorepinephrine
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on NCT01367743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367743.